The FOCUS is on JNJ. Poster presentations can be very detailed, informative and with "speaking" discussions. They often draw large crowds.
The Donald vs. Hillary with the Supreme Court and the Federal Reserve as the top prizes. Also our relations with China (war or peace) are on the table. OH MY!!!
Its all about Janssen's (JNJ) handling of IMET now. Some data from new JNJ trials must be available by now (24 week trials). Do they still maintain that IMET is a transformative, platform medicine? We have to hear the words directly from them. April 19th looks like an important date.
That's my feeling also. JNJ has so many projects going (10 hot pipeline medicines including IMET), that they would not have put this level of resources, medical talent, time ad effort into IMET unless they were sure.
These are 2 different universes: 1.) the universe of the PPS (hedge funds, day trading, naked shorts, general under the radar market manipulation); 2.) The universe of cancer, telomeres and telomerase that will bring treatments, remissions and cures. Someday soon, they will collide, and the heavens will light-up.
Wake up America. Trump as commander and chief means war with China, the end of democracy.in the USA, and Civil War II. This man is amazingly smart, clever and insane. Do not underestimate his talents. The GOP may not be able to stop him.
hTERT and Vaccines (See abstract #2731):
Now with Potential; beyond blood cancers: IMET as a cancer vaccine component; part of the latest trial.
1. The vaccine contains a small fragment of protein from an enzyme called human telomerase reverse transcriptase (hTERT), which allows cancer cells to divide continuously.
2. “We know that the immune system in patients with advanced cancer is suppressed, so it’s unable to recognise and kill cancer cells,” said Professor Hardev Pandah, principal investigator on the trial from the University of Surrey in Guildford.
3. Kelly Potter, 35, was diagnosed with advanced cervical cancer in July 2015 and was among the first to be enrolled on a cancer vaccine trial that will run over the next two years involving up to 30 volunteers.
4. “There are very few solid tumours that shouldn’t be susceptible to this sort of treatment. This is a phase one trial, but we are pretty confident that it will be safe
There will be posters about IMET, but no one knows if there will be updates of the 100+ trials (MF, MDS, blood cancers in general). This is a major update of JNJ's silence.
black--You are "flip-flopping". You say over and over that Dr. S should not be the "leader", and should be gone. In fact, he would likely agree, since he was responsible for the JNJ partnership, and their control of IMET. Also, you said many times that Geron needed a major drug company that "knew the ropes". You believed that Dr. S was hired by Geron to find a partner and/or sell the company. That is playing out.
This is the new focal point for IMET. It is now all about the AACR (New Orleans, April 19). Geron's future and existence depends on JNJ/Janssen's support. JNJ will finally speak, and all will understand about IMET's successes and potential.. Geron has tried to speak about IMET, but few have listened to Scarlett. He is likely part of the planning for this event, but has little credibility with many, so JNJ will now speak out (loud and clear). JNJ has all of the data and analyses.
This only has to do with keeping the Republican party intact, and securing the USA from far right fascist influences that destroyed democracies in the 1930's. We need a two party system, tending toward the center, that knows the meaning of compromise.
"Janssen in control now. And Scarlett may not even be informed"--previous (jwjmurphy)
This is great news. Anything that Geron says seems to lack credibility with the markets, as a small biotech company with an interesting and confusing history. JNJ/Janssen now fully controls IMET, with Janssen conducting the trials, and pushing IMET is many directions simultaneously. Scarlett is still part of the team, but "the big guns" are about to speak. This is what we have been waiting for.
"Janssen and Janssen alone (without Geron!! to muck it up) presenting third week of April 2016 in New Orleans focused all on imetalstat."
The tug-of-war continues between "market-forces" and "medical advances" with "medical advances" now in making a strong comeback.. The power of JNJ in the medical world is well known. JNJ works closely with the FDA and has several recent successes with breakthrough drugs. Everything is in place for new IMET approvals (all positives, no negatives).
I am surprised that others do not see the "Trump-challenge". What will cybersecurity look like in a Trump administration? Will our military and our intelligence communities listen to him? Obviously, Trump must be stopped by any means possible, and Romney is leading the charge.
Will this election affect cybersecurity investments? I think it will. Who is likely to turn China from a competitor and rival into a full time enemy?
Romney is branding the billionaire businessman as "a phony, a fraud" whose "promises are as worthless as a degree from Trump University," according to a speech Romney planned to give at the University of Utah on Thursday morning. The Associated Press obtained excerpts of his remarks in advance.